| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SWTX | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 27, 2021 | Sale | $75.05 | 201 | 15,085 | 144,959 | Apr 28, 2021, 08:18 PM | |
| SWTX | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 28, 2021 | Sale | $76.20 | 19,231 | 1,465,437 | 125,728 | Apr 28, 2021, 08:18 PM | |
| SWTX | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 14, 2021 | Sale | $75.08 | 511 | 38,365 | 146,217 | Apr 19, 2021, 06:07 AM | |
| SWTX | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Apr 15, 2021 | Sale | $75.01 | 1,057 | 79,291 | 145,160 | Apr 19, 2021, 06:07 AM | |
| SWTX | SpringWorks Therapeutics, Inc. | SQUINTO STEPHEN P | Director | Sep 17, 2019 | Buy | $18.00 | 275,000 | 4,950,000 | 7,406,307 | Sep 19, 2019, 07:12 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 27, 2014 | Option Exercise | $62.73 | 5,550 | 348,139 | 112,418 | Oct 28, 2014, 05:41 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 27, 2014 | Sale | $188.58 | 5,910 | 1,114,532 | 108,577 | Oct 28, 2014, 05:41 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 03, 2014 | Option Exercise | $42.66 | 10,025 | 427,666 | 116,893 | Oct 07, 2014, 08:13 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 03, 2014 | Sale | $172.41 | 10,025 | 1,728,374 | 111,793 | Oct 07, 2014, 08:13 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Sep 24, 2014 | Sale | $159.50 | 76 | 12,122 | 106,868 | Sep 26, 2014, 05:53 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 04, 2014 | Sale | $157.42 | 1,662 | 261,632 | 106,944 | Aug 05, 2014, 04:55 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 06, 2014 | Sale | $155.11 | 3,800 | 589,418 | 94,818 | Feb 10, 2014, 06:47 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 07, 2014 | Sale | $155.57 | 1,620 | 252,030 | 102,963 | Feb 10, 2014, 06:47 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 10, 2014 | Sale | $167.31 | 1,635 | 273,552 | 101,308 | Feb 10, 2014, 06:47 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 06, 2014 | Option Exercise | $93.83 | 3,800 | 356,554 | 98,618 | Feb 10, 2014, 06:47 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 03, 2014 | Sale | $157.14 | 852 | 133,883 | 102,216 | Feb 05, 2014, 07:58 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 04, 2014 | Option Exercise | $57.64 | 28,739 | 1,656,469 | 124,455 | Feb 05, 2014, 07:58 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Feb 04, 2014 | Sale | $155.07 | 36,137 | 5,603,781 | 99,016 | Feb 05, 2014, 07:58 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jan 29, 2014 | Sale | $133.31 | 1,118 | 149,039 | 103,086 | Jan 31, 2014, 05:30 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Nov 04, 2013 | Option Exercise | $31.64 | 14,125 | 446,962 | 118,311 | Nov 05, 2013, 06:50 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Nov 04, 2013 | Sale | $123.87 | 14,125 | 1,749,664 | 105,425 | Nov 05, 2013, 06:50 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 28, 2013 | Option Exercise | $81.72 | 40,037 | 3,271,738 | 145,223 | Oct 30, 2013, 05:59 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 28, 2013 | Sale | $124.07 | 40,037 | 4,967,340 | 105,686 | Oct 30, 2013, 05:59 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Oct 28, 2013 | Sale | $123.89 | 1,000 | 123,890 | 104,186 | Oct 30, 2013, 05:59 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Sep 24, 2013 | Sale | $112.54 | 304 | 34,212 | 105,186 | Sep 26, 2013, 04:59 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Sep 13, 2013 | Sale | $114.37 | 1,000 | 114,370 | 105,490 | Sep 17, 2013, 06:09 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 05, 2013 | Sale | $116.87 | 852 | 99,573 | 106,490 | Aug 07, 2013, 05:27 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 02, 2013 | Option Exercise | $31.64 | 14,125 | 446,962 | 121,467 | Aug 02, 2013, 05:02 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Aug 02, 2013 | Sale | $115.33 | 14,125 | 1,629,018 | 116,555 | Aug 02, 2013, 05:02 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jul 30, 2013 | Sale | $110.86 | 1,120 | 124,163 | 107,342 | Aug 01, 2013, 05:04 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jul 12, 2013 | Option Exercise | $21.02 | 18,000 | 378,370 | 126,462 | Jul 16, 2013, 04:47 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | Jul 12, 2013 | Sale | $119.90 | 18,000 | 2,158,200 | 108,462 | Jul 16, 2013, 04:47 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Global Ops. Officer | Jul 01, 2013 | Sale | $94.97 | 44,125 | 4,190,622 | 127,412 | Jul 03, 2013, 04:49 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Global Ops. Officer | Jul 01, 2013 | Option Exercise | $39.13 | 44,125 | 1,726,762 | 152,587 | Jul 03, 2013, 04:49 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Global Ops. Officer | Apr 29, 2013 | Option Exercise | $33.73 | 36,499 | 1,231,027 | 144,961 | May 01, 2013, 06:29 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Global Ops. Officer | Apr 29, 2013 | Sale | $98.96 | 36,499 | 3,612,051 | 108,662 | May 01, 2013, 06:29 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Mar 08, 2013 | Sale | $91.36 | 20,000 | 1,827,162 | 111,547 | Mar 12, 2013, 04:39 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Mar 08, 2013 | Option Exercise | $19.52 | 20,000 | 390,350 | 128,462 | Mar 12, 2013, 04:39 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Feb 04, 2013 | Sale | $95.68 | 2,572 | 246,081 | 81,977 | Feb 06, 2013, 06:07 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Jan 28, 2013 | Sale | $94.50 | 715 | 67,568 | 85,264 | Jan 30, 2013, 05:23 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Head of R&D | Jan 29, 2013 | Sale | $94.32 | 767 | 72,343 | 84,497 | Jan 30, 2013, 05:23 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 31, 2012 | Sale | $105.01 | 1,015 | 106,585 | 85,979 | Jul 31, 2012, 04:44 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 27, 2012 | Option Exercise | $20.96 | 100,000 | 2,096,280 | 187,662 | Jul 31, 2012, 04:44 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 27, 2012 | Sale | $107.28 | 100,668 | 10,800,149 | 161,982 | Jul 31, 2012, 04:44 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 09, 2012 | Option Exercise | $17.98 | 50,000 | 899,000 | 137,662 | Jul 11, 2012, 04:26 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 09, 2012 | Sale | $100.44 | 50,000 | 5,021,772 | 93,562 | Jul 11, 2012, 04:26 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jun 06, 2012 | Option Exercise | $17.65 | 50,000 | 882,500 | 137,662 | Jun 08, 2012, 03:34 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jun 06, 2012 | Sale | $90.00 | 50,000 | 4,500,000 | 87,662 | Jun 08, 2012, 03:34 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Feb 17, 2012 | Option Exercise | $17.10 | 55,260 | 945,048 | 142,922 | Feb 22, 2012, 05:23 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Feb 17, 2012 | Sale | $81.36 | 55,260 | 4,495,938 | 94,441 | Feb 22, 2012, 05:23 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jan 27, 2012 | Sale | $74.41 | 663 | 49,334 | 77,626 | Jan 30, 2012, 05:03 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jan 30, 2012 | Sale | $74.51 | 3,004 | 223,828 | 74,662 | Jan 30, 2012, 05:03 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jan 10, 2012 | Sale | $75.00 | 562 | 42,150 | 78,289 | Jan 11, 2012, 05:26 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Oct 24, 2011 | Option Exercise | $11.92 | 52,740 | 628,661 | 131,591 | Oct 25, 2011, 04:00 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Oct 24, 2011 | Sale | $69.29 | 52,740 | 3,654,394 | 109,724 | Oct 25, 2011, 04:00 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 26, 2011 | Option Exercise | $10.29 | 28,000 | 288,120 | 106,270 | Jul 27, 2011, 04:52 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 26, 2011 | Sale | $57.34 | 28,000 | 1,605,520 | 78,270 | Jul 27, 2011, 04:52 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 27, 2011 | Sale | $57.27 | 669 | 38,314 | 77,601 | Jul 27, 2011, 04:52 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Jul 11, 2011 | Sale | $50.00 | 502 | 25,100 | 78,270 | Jul 12, 2011, 04:09 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Mar 02, 2011 | Option Exercise | $20.58 | 5,000 | 102,900 | 44,637 | Mar 04, 2011, 03:50 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research & Development | Mar 02, 2011 | Sale | $99.11 | 5,000 | 495,550 | 39,637 | Mar 04, 2011, 03:50 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research and Development | Feb 18, 2011 | Option Exercise | $20.58 | 10,000 | 205,800 | 49,637 | Feb 23, 2011, 04:53 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP, Research and Development | Feb 18, 2011 | Sale | $94.42 | 10,000 | 944,200 | 39,637 | Feb 23, 2011, 04:53 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 27, 2011 | Sale | $84.70 | 1,330 | 112,651 | 32,917 | Jan 28, 2011, 04:29 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 18, 2011 | Option Exercise | $14.59 | 34,000 | 496,000 | 68,247 | Jan 18, 2011, 05:03 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 18, 2011 | Sale | $85.00 | 34,346 | 2,919,280 | 34,247 | Jan 18, 2011, 05:03 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Jan 10, 2011 | Sale | $81.27 | 280 | 22,756 | 34,593 | Jan 12, 2011, 01:02 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Nov 03, 2010 | Option Exercise | $10.36 | 10,000 | 103,600 | 44,873 | Nov 05, 2010, 04:30 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Nov 03, 2010 | Sale | $70.14 | 10,000 | 701,400 | 34,873 | Nov 05, 2010, 04:30 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Sep 13, 2010 | Option Exercise | $11.06 | 12,416 | 137,346 | 42,289 | Sep 13, 2010, 04:36 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | SQUINTO STEPHEN P | EVP & Head of R&D | Sep 13, 2010 | Sale | $60.89 | 12,416 | 756,010 | 34,873 | Sep 13, 2010, 04:36 PM |
Menu